Table 2. Summary of genomes by region.
| Region | Total genomes | *Representative cases 2010–2020 | †Travel (%) amongst representative cases 2010–2020 |
|---|---|---|---|
| Australia and NZ | 57 | 57 | 0 (0%) |
| Caribbean | 20 | 20 | 20 (100%) |
| Central America | 103 | 100 | 100 (100%) |
| Eastern Africa | 1106 | 830 | 49 (5.9%) |
| Eastern Asia | 12 | 3 | 3 (100%) |
| Eastern Europe | 3 | 1 | 1 (100%) |
| Melanesia | 232 | 37 | 30 (81.1%) |
| Micronesia | 4 | 1 | 1 (100%) |
| Middle Africa | 59 | 21 | 6 (28.6%) |
| Northern Africa | 41 | 6 | 6 (100%) |
| Northern America | 167 | 140 | 2 (1.4%) |
| Northern Europe | 109 | 105 | 0 (0%) |
| Polynesia | 324 | 262 | 45 (17.2%) |
| South America | 367 | 105 | 5 (4.8%) |
| South-eastern Asia | 1140 | 584 | 72 (12.3%) |
| Southern Africa | 317 | 286 | 2 (0.7%) |
| Southern Asia | 8231 | 6623 | 1878 (28.4%) |
| Southern Europe | 10 | 6 | 6 (100%) |
| Western Africa | 384 | 267 | 34 (12.7%) |
| Western Asia | 47 | 21 | 21 (100%) |
| Western Europe | 7 | 3 | 3 (100%) |
| Unknown | 225 | 0 | 0 |
| Total | 12965 | 9478 | 2284 (24.1%) |
*
Genomes associated with assumed acute typhoid cases, isolated from 2010 onwards from non-targeted sampling frames; this is the subset of data used to generate genotype prevalence distributions shown in Figures 1—3.
†
Genomes recorded as travel-associated and with known travel to a specific country in this region, associated with assumed acute typhoid isolated from 2010 onwards from non-targeted sampling frames. Countries were assigned to world regions based on the United Nations (UN) Statistics Division standard M49.